Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Res. 2015 May 22;75(15):3167–3180. doi: 10.1158/0008-5472.CAN-14-3701

Figure 1. Generation of BrafFA mice.

Figure 1

A. Schematic representation of the targeting construct used to generate the BrafFA mouse through homologous recombination into the endogenous Braf genomic locus of 129SvEv derived ES cells.

B. Schematic of the structure of the BrafFA allele that expresses normal BRAF and NEO prior to Flp-mediated recombination. P1 and P2 indicate the location of Southern blotting probes used to confirm appropriate targeting of the Braf gene.

C. Schematic of the structure of the BrafFA allele following Flp-mediated recombination that now expresses mutationally activated BRAFV600E.

D. Southern blot analysis to identify ES clones with the BrafFA targeting construct.

E. H&E stained sections of BrafFA (left) and BrafCA (right) 10 weeks p.i. with Ad-Flp or Ad-Cre respectively with average tumor burden indicated in the bar graph.

F. Lung sections of tumor-bearing BrafFA or BrafCA mice stained with H&E, Ki67, anti-SPC/CC10 or AQP5 using either IHC and IF methods as indicated.

G. Immunoblot analysis of lung tumor lysates from BrafFA or BrafCA mice 10 weeks p.i.